Blue Clay Capital Management’s NeoGenomics NEO Stock Holding History

Blue Clay Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$104K	Buy	+12,600	New	+$106K	0.12%	95

Other funds holding NEO

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Artisan Partners

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Blue Clay Capital Management's NEO Position: Q3 2016 in Review

Blue Clay Capital Management opened a new position in NeoGenomics (NEO) in Q3 2016: 12,600 shares worth $104K. The stake represents 0.12% of the portfolio and ranks #95 among its holdings.

137 funds tracked by Wall St. Rank hold NEO as of Q3 2016.

Blue Clay Capital Management held 12,600 shares of NeoGenomics worth $104K as of Q3 2016.
NeoGenomics was a new Blue Clay Capital Management position in Q3 2016.
NeoGenomics made up 0.12% of Blue Clay Capital Management's portfolio in Q3 2016, its #95 holding.
137 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2016.

Based on Blue Clay Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.